Following the money trail from the PCR patent owner and finding the truth
surprise they're all linked to Switzerland, WW2, NASA, Nazis, L.S.D and government pension schemes JP Morgan and the military industrial complex and finally
Bill the gates of hell
seriously just keep on reading right to the end to see just how far the web of fuckery has been spun
owned by Hoffman-LaRoche and PerkinElmer
PerkinElmer (UK)Parent organisations linked to NASA Nazis L.S.D and the military industrial complex
pcr test patent owner
PerkinElmer (UK)
Company
Ceased operations: 28 October 2014
Key Facts
Our Mission: Innovating for a healthier world
President and Chief Executive Officer: Prahlad Singh
2019 Revenue: Approximately $2.9 billion
Global Headquarters: Waltham, MA
Number of Patents: 3,500
Ticker Symbol: PKI (NYSE)
Search Results
Corporate Officers
President and Chief Executive Officer
Senior Vice President, Administration,
General Counsel and Secretary
Senior Vice President and Chief Financial Officer
Vice President and Chief
Accounting Officer
Senior Vice President, Strategy and Business Development
Senior Vice President, Global OperationsFeatured snippet from the webAs part of the sale, rights to the PCR patents were sold for USD $300 million to Hoffman-La Roche (who in 1989 had bought limited rights to PCR). Many of the Cetus PCR researchers moved to the Roche subsidiary, Roche Molecular Systems.
Search Results
Featured snippet from the web
As part of the sale, rights to the PCR patents were sold for USD $300 million to Hoffman-La Roche (who in 1989 had bought limited rights to PCR). Many of the Cetus PCR researchers moved to the Roche subsidiary, Roche Molecular Systems.
PerkinElmer
From Wikipedia, the free encyclopedia
PerkinElmer, Inc.
Type Public
Industry Medtech
Founded 1937
Founder Richard Scott Perkin 
Headquarters Waltham, Massachusetts, U.S.
Key people Prahlad Singh, President and Chief Executive Officer
Products Analytical instruments, lab technologies, diagnostic testings, laboratory services, informatics, cord blood banking
Number of employees About 13,000
Website www.perkinelmer.com
PerkinElmer, Inc., is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.
PerkinElmer is part of the S&P 500 Index and operates in 150 countries.
Contents
History[edit]
Founding companies[edit]
PerkinElmer was founded in 1937[2] by Richard Perkin and Charles Elmer as an optical design and consulting company. In 1944, Perkin-Elmer entered the analytical-instruments business, and in the early 1990s, partnered with Cetus Corporation (and later Hoffmann-La Roche) to pioneer the polymerase chain reaction (PCR) equipment industry. Analytical-instruments business was also operated from 1954 to 2001 in Germany, by the Bodenseewerk Perkin-Elmer GmbH located in Ãœberlingen at Lake Constance, and England (Perkin Elmer Ltd) at Beaconsfield in Buckinghamshire.
EG&G was founded in 1931 by two MIT professors, Harold Edgerton and Kenneth Germeshausen in a Boston garage. The company was originally incorporated in 1947 as EG&G.
Computer Systems Division[edit]
Perkin-Elmer was involved in computer manufacture for a time. The Perkin-Elmer Computer Systems Division was formed through the purchase of Interdata, Inc., an independent computer manufacturer, in 1973–74 for some $63 million.[3][4] This merger made Perkin-Elmer's annual sales rise to over $200 million.[4] This was also known as Perkin-Elmer's Data Systems Group.[5]
The 32-bit computers were very similar to an IBM System/370, but ran the OS/32MT operating system.
The Wollongong Group provided the commercial version of the Unix port to the Interdata 7/32 hardware, known as Edition 7 Unix. The port was originally done by the University of Wollongong in New South Wales, Australia, and was the first UNIX port to hardware other than the Digital Equipment Corporation PDP family. By 1982 the Wollongong Group Edition 7 Unix and Programmer's Workbench (PWB) were available on models such as the Perkin-Elmer 3210 and 3240 minicomputers.
In 1985, the computing division of Perkin-Elmer was spun off as Concurrent Computer Corporation.[6]
1999[edit]
Modern PerkinElmer traces its history back to a merger between divisions of what had been two S&P 500 companies, EG&G Inc. (formerly NYSE: EGG) of Wellesley, Massachusetts and Perkin-Elmer (formerly NYSE: PKN) of Norwalk, Connecticut. On May 28, 1999, the non-government side of EG&G Inc. purchased the Analytical Instruments Division of Perkin-Elmer, its traditional business segment, for US$425 million, also assuming the Perkin-Elmer name and forming the new PerkinElmer company, with new officers and a new Board of Directors.[7][8] At the time, EG&G made products for diverse industries including automotive, medical, aerospace and photography.[8]
The old Perkin-Elmer Board of Directors and Officers remained at that reorganized company under its new name, PE Corporation. It had been the Life Sciences division of Perkin-Elmer, and its two component tracking stock business groups, Celera Genomics (NYSE: CRA) and PE Biosystems (formerly NYSE: PEB), were centrally involved in the highest profile biotechnology events of the decade, the intense race against the Human Genome Project consortium, which then resulted in the genomics segment of the technology bubble. Perkin-Elmer purchased the Boston operations of NEN Life Sciences in 2001.
PerkinElmer headquarters in Waltham
Recently[edit]
In 1992, the company merged with Applied Biosystems. In 1997 they merged with PerSeptive Biosystems. On July 14, 1999, the new analytical instruments maker PerkinElmer cut 350 jobs, or 12%, in its cost reduction reorganization.[8] In 2006, PerkinElmer sold off the Fluid Sciences division for approximately $400M; the aim of the selloff was to increase the strategic focus on its higher-growth health sciences and photonic markets. Following on from the selloff, a number of small businesses were acquired, including Spectral Genomics, Improvision, Evotec-Technologies, Euroscreen, ViaCell, and Avalon Instruments. The brand "Evotec-Technologies" remains the property of Evotec, the former owner company. PerkinElmer had a license to use the brand till the end of year 2007.
PerkinElmer has continued to expand its interest in medicine with the acquisitions of clinical laboratories, In July 2006, it acquired NTD Labs located on Long Island, New York. The laboratory specializes in prenatal screening during the first trimester of pregnancy. In 2007, it purchased ViaCell, Inc. for $300 million,[9] which included its offices in Boston and cord blood storage facility in Kentucky near Cincinnati. The company was renamed ViaCord.
In March 2008, PerkinElmer purchased Pediatrix Screening (formerly Neo Gen Screening), a laboratory located in Bridgeville, PA specializing in screening newborns for various inborn errors of metabolism such as phenylketonuria, hypothyroidism, and sickle-cell disease. It renamed the laboratory PerkinElmer Genetics, Inc.
In May 2011, PerkinElmer announced the signature of an agreement to acquire CambridgeSoft, and the successful acquisition of ArtusLabs.[10]
In September 2011, PerkinElmer bought Caliper Life Sciences for $600 million.[11]
In January 2017, the company announced it would acquire the Indian in vitro diagnostic company, Tulip Diagnostics.[12] In May of the same year the company acquired Euroimmun Medical Laboratory Diagnostics for approximately $1.3 billion.[13]
In 2018, the company acquired Australian biotech company, RHS Ltd., Chinese manufacturer of analytical instruments, Shanghai Spectrum Instruments Co. Ltd., and US company Cisbio Bioassays, which specializes in diagnostics and drug discovery solutions.[14][15][16]
Programs[edit]
Hubble optics project[edit]
Polishing of Hubble's primary mirror begins at Perkin-Elmer corporation, Danbury, Connecticut, May 1979. The engineer pictured is Dr. Martin Yellin, an optical engineer working for Perkin-Elmer on the project.
Perkin-Elmer's Danbury Optical System unit[17] was commissioned to build the optical components of the Hubble Space Telescope. The construction of the main mirror began in 1979 and completed in 1981. The polishing process ran over budget and behind schedule, producing significant friction with NASA. Due to a miscalibrated null corrector, the primary mirror was also found to have a significant spherical aberration after reaching orbit on STS-31. Perkin-Elmer's own calculations and measurements revealed the primary mirror's surface discrepancies, but the company chose to withhold that data from NASA. A NASA investigation heavily criticized Perkin-Elmer for management failings, disregarding written quality guidelines, and ignoring test data that revealed the miscalibration.[18] Corrective optics were installed on the telescope during the first Hubble service and repair mission STS-61. The correction, Corrective Optics Space Telescope Axial Replacement, was applied entirely to the secondary mirror and replaced existing instrumentation; the aberration of the primary mirror remained uncorrected.
The company agreed to pay US $15 million, essentially forgoing its fees in polishing the mirror, to avoid a threatened liability lawsuit under the False Claims Act by the Federal government. Hughes Aircraft which acquired the Danbury Optical System unit one month after the launch of the telescope, paid $10 million. The Justice Department asserted that the companies should have known about the flawed testing. Trade group Aerospace Industries Association protested when concerns were raised in the aerospace industry that aerospace companies might be held liable for failed equipment.[17]
KH-9 Hexagon[edit]
Perkin-Elmer built the optical systems for the KH-9 Hexagon series of spy satellites at a facility in Danbury, Connecticut.[19]
In the 1970s, an aerial panoramic camera lens was capable of recording the entire state of Pennsylvania in two flyovers, with resolution that enabled one to count the autos on the Pennsylvania Turnpike.[20]
you will like this bit
Nucleic Acid Isolation and PCR Setup direct from their webpage
Improving the efficiency of PCR workflows
We offer automated solutions for nucleic acid isolation and PCR setup to increase the throughput and reproducibility of PCR workflows for virtually any application. Our automated solutions for nucleic acid isolation, analysis, purification of PCR products, and PCR setup are designed to increase the efficiency of endpoint, real-time, RT, and multiplex PCR experiments.
PerkinElmer offers several different solutions for automated nucleic acid isolation based on your sample volume and throughput needs. These solutions are grounded in the proprietary chemagen™ bead-based nucleic acid isolation technology, delivering high-yield and purity DNA and RNA for PCR analysis. Additionally, we offer solutions for PCR product purification PCR products, which removing impurities that maintain PCR yield.
PerkinElmer offers automated microfluidic devices simplifying the analysis of input concentration and qualitative assessment of PCR products replacing the multiple, manual steps of slab gel electrophoresis with high levels of accuracy and throughput.
With liquid handlers ranging in size from benchtop to large integrated workstations, PerkinElmer offers PCR setup automation solutions to meet any of your throughput needs.
Explore the areas below to learn how you can increase the efficiency of your PCR experiments.
👉👉For research use only. Not for use in diagnostic procedures.👈👈
screen cap see last line
👉
On 26 March 2009, Roche acquired Genentech for $46.8 billion.
Search Results
Roche Holding AG/Parent organizations
Roche Holding AG
More about Roche Holding AG
How much of Roche does Novartis own?
33.3%
Novartis AG owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group. Novartis AG also holds 33.3% of the shares of Roche however, it does not exercise control over Roche. Novartis also has two significant license agreements with Genentech, a Roche subsidiary.
Novartis/CEO
1 Feb 2018–
DescriptionVasant "Vas" Narasimhan is an Indian American physician and the chief executive officer of Novartis. Wikipedia
Did GSK buy Novartis?
GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business. GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion (£9.2 billion).27 Mar 2018
Who owns Novartis AG?
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group. Novartis AG owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group
Who bought Alcon?
Novartis
Novartis acquired Alcon in 2011 from Nestle for $52 billion. When Alcon was acquired by Novartis, the company's business focus included surgical equipment, eye drugs and products such as contact lenses and eye drops
What does Alcon mean in English?
ALCON, a U.S. military standard abbreviation for "all concerned"; see List of U.S. government and military acronyms.
Where did Alcon stock come from?
The company, while based in Switzerland, is headed by an American, reports its results in dollars, and gets about 40% of its sales in the U.S. Alcon generates 25% of revenues from emerging markets, one of the highest percentages among its peers, according to Wells Fargo.12 Apr 2019
Novartis AG
SWISS COMPANY
WRITTEN BY:
Novartis AG, Swiss company that is one of the world’s largest manufacturers of pharmaceuticals. It was formed in 1997 from the merger of two major Swiss drug companies, Ciba-Geigy AG and Sandoz AG. Novartis is headquartered in Basel.
Ciba-Geigy originated in the merger of two smaller Swiss firms, Ciba AG and J.R. Geigy SA. Ciba developed from a silk-dyeing business owned by Alexander Clavel, who began manufacturing the synthetic dye fuchsine in 1859. In 1873 Clavel sold his business to a partnership, Bindschedler & Busch, which expanded the range of dyestuffs produced. In 1884 the firm was transformed into a limited-liability company called the Gesellschaft für Chemische Industrie Basel (“Society of Chemical Industry in Basel”), the last words of which produced the acronym Ciba, which became its familiar name. (In 1945 the company’s name legally became Ciba AG.) In addition to dyes, Ciba became known for pharmaceuticals, which it began making in 1900. By then it had become the largest chemical company in Switzerland.
Geigy dates to 1758, when Johann Rudolf Geigy set up shop in Basel as a chemist and druggist; his son and grandson branched into dyes for the textile industry. In 1868 the founder’s great-grandson, Johann Rudolf Geigy-Merian, assumed command, creating a flourishing dyestuff company that went public in 1901 and was named J.R. Geigy SA in 1914. In the 1930s and ’40s it branched out into agricultural chemicals and pharmaceuticals. One of Geigy’s researchers, Paul Müller, won a Nobel Prize in 1948 for discovering the insecticidal properties of DDT.
Sandoz AG originated in 1886, when Alfred Kern and Edouard Sandoz founded a firm in Basel to make synthetic dyes. The new firm, Chemische Fabrik Kern & Sandoz (“Chemical Company Kern & Sandoz”), grew rapidly, and in 1895, the year it began making pharmaceuticals, it was transformed into a joint-stock company called Chemische Fabrik vormals Sandoz (“Chemical Company formerly Sandoz”). In the 1920s and ’30s it began making cleaning agents and other household products.
Ciba, Geigy, and Sandoz collectively constituted the entire chemical industry of Switzerland. In 1918 the three companies joined together to form a cartel, the Interessengemeinschaft Basel (“Basel Syndicate”), or Basel IG, in order to compete with the German chemical cartel IG Farben. All three companies also established or acquired factories in various European countries and in the United States. In 1929–32 the Basel IG joined with IG Farben and French and British chemical firms to form the Quadrapartite Cartel, which lasted until the outbreak of World War II in 1939. Though each participant in the cartel retained its legal autonomy, the companies, by signed agreement, entered into a division of markets and some joint manufacturing. Basel IG survived the war, but it dissolved in 1951 partly out of regard for U.S. antitrust legislation.
All three Swiss companies prospered and continued to diversify in the decades after World War II, though Sandoz earned an unwelcome notoriety in the 1960s when one of its inventions, a potent hallucinogen called LSD, became a favourite illicit drug in the United States and Europe. In 1970 Ciba and Geigy merged to form Ciba-Geigy AG, and in 1996, in the midst of a wave of consolidations and mergers sweeping the pharmaceutical industry, this company merged with Sandoz AG to form one of the largest drug companies in the world. This merger was one of the largest in corporate history up to that time. Novartis AG has affiliates in about 140 countries and is engaged in the development, manufacture, and marketing of pharmaceuticals, herbicides and insecticides, over-the-counter medications, veterinary medicines, and garden products.
Nearly half the company’s annual revenue is earned in the United States.
so say no to big pharma drugs
Name Age Since Title
52 2015 Chief Executive Officer & Executive Director
Christoph Franz 59 2014 Chairman
Alan Hippe, Dr. 68 2011 Chief Financial & Information Technology Officer
Paul Bulcke 64 2012 Non-Executive Director
André S. Hoffmann 60 2012 Vice Chairman
Bernard J. Poussot 67 2015 Non-Executive Director
Richard P. Lifton, Dr. 66 2015 Non-Executive Director
Claudia Süssmuth Dyckerhoff, Dr. 52 2016 Director
Julie Brown 57 2016 Director
Anita Hauser 50 2017 Director
Equities
Vote 
Quantity Float Company-owned shares Total Float
Quantity Float Company-owned shares Total Float
Stock A 1 702,562,700 695,753,444 99.0% 6,806,245 1.0% 83.7%
Stock B 1 160,000,000 26,339,231 16.5% 0 0.0%
Shareholders
Name Equities %
The Vanguard Group, Inc. 22,098,099 3.15%
Who owns the Vanguard Group?
Founder and former chairman John C. Bogle is credited with the creation of the first index fund available to individual investors, and was a proponent and major enabler of low-cost investing by individuals. Vanguard is owned by the funds managed by the company, and is therefore owned by its customers
Is Vanguard Group Inc publicly traded?
Vanguard has a fairly unique structure in terms of investment management companies. The company is owned by its funds. ... The company has no outside investors other than its stockholders
and at the top of the list of stockholders in apple and therefore bill gate's, is the vanguard group who ultimately profit from the PCR tests showing a clear conflict of interests for a #fact
Top 10 Owners of Apple Inc
StockholderStakeShares
ownedTotal value ($)Shares
bought / soldTotal
change
The Vanguard Group, Inc. 7.36% 321,838,023 81,840,190,869 -2,907,431 -0.90%
Berkshire Hathaway Owner: Warren Buffett, Inc. (Investm... 5.60% 245,155,566 62,340,608,878 -3,683,113 -1.48%
BlackRock Fund Advisors Owner:Laurence D. Fink offshoot of private-equity firm Blackstone Group to the world's largest money manager4.34% 189,855,411 48,278,332,463 -1,466,944 -0.77%
SSgA Funds Management Owner: SSgA Funds Management, Inc. is the investment adviser of the SPDR O-Strip ETF and a wholly owned subsidiary of State Street Corporation CEO: Ronald P. O'Hanley, Inc. 4.18% 182,854,781 46,498,142,260 -1,377,664 -0.75%
Fidelity Management & Research Co Owner: the Johnson family. The family, along with a small group of FMR employees and shareholders, are also investors in F-Prime Capital, the private venture capital arm... 2.02% 88,533,508 22,513,185,749 -1,152,613 -1.29%
Geode Capital Management LLC Owner a whole bunch of people including Arlene Rockefeller
GEODE CAPITAL MANAGEMENT, LLC
ownership team - last updated 2019-12-09
Name Title Start Date Direct/Indirect % Ownership
GEODE CAPITAL HOLDINGS LLC MEMBER 08/01/2003 Direct 75% or more
LORING, CALEB DIRECTOR 07/01/2003 Direct less than 5%
MILLER, JEFFREY, STEWART CHIEF OPERATING OFFICER 06/01/2006 Direct less than 5%
GUBITOSI, VINCENT, CHARLES PRESIDENT AND CHIEF INVESTMENT OFFICER 10/01/2009 Direct less than 5%
CIARDI, JOSEPH, LOUIS CHIEF COMPLIANCE OFFICER 01/01/2010 Direct less than 5%
ROCKEFELLER, ARLENE DIRECTOR 05/01/2011 Direct less than 5%
KENLY, FRANKLIN, CORNING DIRECTOR 04/01/2012 Direct less than 5%
ROITER, ERIC, DANIEL DIRECTOR 10/01/2012 Direct less than 5%
UHRIG, JENNIFER, STONESTREET DIRECTOR 10/01/2013 Direct less than 5%
CODREANU, SORIN CHIEF FINANCIAL OFFICER 10/01/2013 Direct less than 5%
NEVINS, MATTHEW, JOEL GENERAL COUNSEL 02/01/2015 Direct less than 5%
BULLEN, PHILIP, LINDSEY DIRECTOR 02/01/2017 Direct less than 5%
Sprague, Thomas DIRECTOR 02/01/2019 Direct less than 5%
GEODE SERIES COMMODITY RETURN CAYMAN LTD. Cayman Islands 805-9645208847 Hedge Fund 375,653,013 0
GEODE COMMODITY RETURN CENTRAL CAYMAN LTD. Cayman Islands 805-7847181016 Hedge Fund 26,294,021 0
GEODE COMMODITY STRATEGY CAYMAN LTD. Cayman Islands 805-3420232257 Hedge Fund 32,063,239 0
GEODE SAI INFLATION FOCUSED CAYMAN LTD. Cayman Islands 805-3933940758 Hedge Fund 1,774,548 0
1.43% 62,482,090 15,888,570,666 +789,746 +1.28%
******************
Northern Trust Investments owner through various corporations its owned by Michael G. O'Grady of Northern Trust, Inc.(... 1.26% 55,032,139 13,994,122,626 -663,154 -1.19%
T. Rowe Price Associates shareholders
Mutual fund Stake Shares
owned Total value ($) Shares
bought / sold Total
change
Vanguard Total Stock Market Index... 2.79% 6,510,396 635,740,169 +121,047 +1.89%
Vanguard 500 Index Fund 2.06% 4,809,119 469,610,470 +56,171 +1.18%
SPDR S&P 500 ETF 1.08% 2,524,109 246,479,244 -41,860 -1.63%
Government Pension Fund - Global ... 0.97% 2,270,027 221,668,137 +6,837 +0.30%
JPMorgan Mid Cap Value Fund 0.95% 2,214,297 216,226,102 -20,014 -0.90%
Vanguard Dividend Appreciation In... 0.93% 2,170,269 211,926,768 +43,003 +2.02%
Fidelity 500 Index Fund 0.90% 2,087,909 203,884,314 +26,318 +1.28%
MFS Value Fund 0.89% 2,087,222 203,817,228 -17,597 -0.84%
Vanguard Institutional Index Fund 0.89% 2,068,727 202,011,192 -6,600 -0.32%
JPMorgan Equity Income Fund 0.86% 2,000,240 195,323,436 +5,036 +0.25%, Inc. (I... 1.18% 51,779,477 13,167,003,206 +27,080,346 +109.64%
Norges Bank Investment Management We manage the Government Pension Fund Global, often referred to as the Norwegian oil fund run by but not owned by Øystein Olsen owned by Ministry of Finance (Norway)1.07% 46,856,273 11,915,081,661 -692,563 -1.46%
BlackRock Investment Management (... 0.71% 30,896,763 7,856,737,863 -326,580 -1.05%
Top 10 Mutual Funds Holding Apple Inc
Top 10 Mutual Funds Holding Apple Inc
Mutual fundStakeShares
ownedTotal value ($)Shares
bought / soldTotal
changeVanguard Total Stock Market Index... 2.68% 117,244,991 29,814,228,761 +2,036,365 +1.77%
Vanguard 500 Index Fund 1.96% 85,955,102 21,857,522,888 +998,377 +1.18%
Government Pension Fund - Global ... 1.04% 45,329,151 11,526,749,808 -603,877 -1.31%
SPDR S&P 500 ETF 1.03% 45,111,056 11,471,290,430 -750,490 -1.64%
Fidelity 500 Index Fund 0.85% 37,318,624 9,489,752,897 +470,402 +1.28%
Vanguard Institutional Index Fund 0.85% 36,959,990 9,398,555,857 -133,400 -0.36%
Invesco QQQ Trust 0.83% 36,167,057 9,196,920,925 -239,457 -0.66%
iShares Core S&P 500 ETF 0.72% 31,463,747 8,000,916,225 -55,198 -0.18%
Vanguard Growth Index Fund 0.69% 30,345,189 7,716,478,111 +77,575 +0.26%
Vanguard Information Technology I... 0.42% 18,442,201 4,689,667,292 +358,625 +1.98%
Norges Bank Investment Management 19,422,629 2.76%
Fidelity Management & Research Co. 13,286,250 1.89%
UBS Asset Management Switzerland AG 11,725,275 1.67%
BlackRock Fund Advisors 10,482,981 1.49%
Credit Suisse Asset Management (Schweiz) AG 8,655,350 1.23%
Massachusetts Financial Services Co. 7,646,488 1.09%
Zürcher Kantonalbank (Investment Management) 7,236,859 1.03%
Roche Holding AG 6,800,000 0.97%
FIL Investment Advisors (UK) Ltd. 5,687,373 0.81%
Holdings
Name Equities % Valuation
Chugai Pharmaceutical Co., Ltd. (4519) 335,223,000 59.9% 38,815,132,595 USD
Roche Holding AG (ROG) 6,800,000 0.97% 2,207,162,360 USD
Senseonics Holdings, Inc. 28,345,276 13.9% 17,942,560 USD
Millendo Therapeutics, Inc. (MLND) 1,089,180 5.96% 5,750,870 USD
Bill defo has more than a conflict of interest as all the companies such as the ig farben have stock in his company
#WakeUp
